Simplify Processes, Maximize Reimbursements, Empower Care
Neurology billing is among the most documentation-intensive specialties in healthcare. Managing complex diagnostic testing, neuroimaging, procedures, and long-term chronic disease care — across outpatient, inpatient, and telehealth settings — demands precision at every step of the revenue cycle.
This 2026 neurology billing and coding guide covers everything your practice needs to remain compliant and protect revenue: CPT codes, ICD-10-CM diagnosis mapping, modifier usage, tele-neurology billing, denial prevention, and audit readiness.
Partner with Neolytix to bring precision, efficiency, and expertise to your neurology billing operations.
- Neolytix • Medical Billing
Medical Billing
Neurology CPT Codes Quick-Reference Cheat Sheet (2026)
The most frequently billed neurology CPT codes organized by service category. Use this as a daily coding reference — full details and documentation requirements are in each section below.
Evaluation & Management
| CPT | Service | 2026 wRVU |
|---|---|---|
| 99202–99205 | New patient outpatient E&M | 0.93 – 3.50 |
| 99212–99215 | Established patient outpatient E&M | 0.70 – 2.11 |
| 99221–99223 | Initial hospital care | 1.28 – 2.65 |
| 99231–99233 | Subsequent inpatient care | 0.76 – 1.39 |
| 99417 | Prolonged service add-on (time-based) | 0.61 per 15 min |
EEG & Neurodiagnostics
| CPT | Service | Notes |
|---|---|---|
| 95816 | Routine EEG, awake and drowsy | Requires signed interpretation |
| 95819 | Routine EEG, awake and asleep | Requires signed interpretation |
| 95812 | EEG, 41–60 minutes | Document exact duration |
| 95813 | EEG, >1 hour | Document exact duration |
| 95700 | Long-term EEG (LTM) setup/takedown | Bill once per episode |
| 95711–95716 | LTM technical recording (time-tiered) | 2 hr → >48 hr tiers |
| 95718–95726 | LTM professional interpretation | Tiered by duration |
| 95930 | Visual evoked potentials (VEP) | Pattern reversal or flash |
| 95925–95928 | Somatosensory evoked potentials (SSEP) | Upper/lower extremity; per side |
EMG & Nerve Conduction Studies
| CPT | Service | 2026 wRVU |
|---|---|---|
| 95886 | Needle EMG, complete (5+ muscles, 3+ nerves) | 1.56 |
| 95885 | Needle EMG, limited (same day as NCS) | 0.90 |
| 95907 | NCS 1–2 studies | 0.65 |
| 95910 | NCS 7–8 studies | 1.25 |
| 95911 | NCS 9–10 studies | 1.45 |
| 95913 | NCS 13+ studies | 1.85 |
Sleep, Chemodenervation & Other High-Volume
| CPT | Service | Key Requirement |
|---|---|---|
| 95810 | Polysomnography ≥6 parameters, attended | Physician interpretation required |
| 95806 | Sleep study, unattended, w/ respiratory effort | No technician present |
| 64615 | Chemodenervation, chronic migraine | Max 1 treatment/12 weeks |
| 64642 | Chemodenervation, 1 extremity (spasticity) | Bill with J0585 separately |
| J0585 | OnabotulinumtoxinA per unit (drug supply) | Always separate line item |
| 62270 | Lumbar puncture, diagnostic | CSF analysis justification |
| 62272 | Lumbar puncture, therapeutic | ICP reduction documentation |
| 96116 | Neurobehavioral status exam, first hour | Physician or NPP face-to-face |
| 96121 | Neurobehavioral status exam, add-on per hour | Report with 96116 |
Overview of Neurology Billing in 2026
Neurology billing is among the most documentation-intensive and denial-prone specialties in US healthcare. Claim denial rates in neurology average 18% — compared to the 5–10% industry average across specialties — driven by documentation gaps, incorrect modifier use, NCCI bundling violations, and failure to meet payer medical necessity standards for high-cost diagnostic services.
Key areas of focus for neurology billing in 2026 include:Â
- Tele-neurology service expansionÂ
- AI-assisted diagnostics and documentation requirementsÂ
- EEG and EMG utilization reviewsÂ
- National Correct Coding Initiative (NCCI) bundling enforcementÂ
2026 Conversion Factors:
CMS introduced dual conversion factors for 2026:
$33.57for APM participants and
$33.40for non-APM providers.
For high-volume neurology services like EMG and NCS, even marginal per-unit differences accumulate significantly across thousands of monthly claims.
Evaluation & Management (E&M) Codes
| CPT Code | Description | MDM Level | Time (Total DOS) |
|---|---|---|---|
| 99202 | New patient, low complexity | Straightforward | 15–29 min |
| 99203 | New patient, moderate complexity | Low | 30–44 min |
| 99204 | New patient, moderate complexity | Moderate | 45–59 min |
| 99205 | New patient, high complexity | High | 60–74 min |
| 99212 | Established patient, minimal | Straightforward | 10–19 min |
| 99213 | Established patient, low | Low | 20–29 min |
| 99214 | Established patient, moderate | Moderate | 30–39 min |
| 99215 | Established patient, high | High | 40–54 min |
| 99417 | Prolonged service add-on (per 15 min) | — | Each 15 min beyond 99215 |
MDM Two-of-Three Rule
MDM is evaluated across three elements: (1) number and complexity of problems addressed, (2) amount and complexity of data reviewed, and (3) risk of complications or morbidity. The final E&M level is determined by meeting at least two of three elements at the same level — not all three. This rule is frequently misunderstood and is a leading source of both undercoding and audit risk in neurology.
Chronic neurological conditions — epilepsy, multiple sclerosis, Parkinson’s disease — typically qualify for moderate or high MDM complexity given the chronic disease management, prescription drug management risk, and diagnostic uncertainty involved.
Common E&M Errors in Neurology:
Upcoding without documented MDM complexity • Billing E&M with a same-day procedure without Modifier 25 • Using time-based billing without exact documented time • Missing linkage to ICD-10-CM diagnosis codes
Inpatient & Consultations
| CPT | Description |
|---|---|
| 99221–99223 | Initial hospital care (straightforward → high complexity) |
| 99231–99233 | Subsequent inpatient care |
| 99238–99239 | Hospital discharge management |
| 99242–99245 | Outpatient consultation (non-Medicare payers) |
Note: Medicare does not recognize outpatient consultation codes 99241–99245. Report using the appropriate new or established patient E&M code instead and document the referring/requesting provider.
EEG & Neurodiagnostic Codes
EEG billing encompasses routine studies, long-term monitoring, ambulatory EEG, and video EEG — each governed by distinct coding rules, component billing requirements, and documentation standards. Missing or unsigned interpretation reports remain the single most common denial trigger for all EEG claims.
Routine EEG
| CPT | Description | Key Distinction |
|---|---|---|
| 95816 | EEG, awake and drowsy | Patient conscious; approximately 20-minute study |
| 95819 | EEG, awake and asleep | Captures both conscious and subconscious brain activity; typically sleep-deprived patient |
| 95812 | EEG, 41–60 minutes | Must document exact start/stop time |
| 95813 | EEG, greater than 1 hour | Continuous recording; document total duration |
95816 vs 95819:
95816 is used when the patient is awake and drowsy — the standard first-line epilepsy screening study. 95819 adds sleep recording, typically for sleep-deprived patients where capturing brain activity transitions is clinically necessary. Do not bill both codes for the same encounter.
Long-Term EEG Monitoring (LTM) — 95700–95726 Series
Long-term EEG replaced the older 95950–95953 series after CPT restructuring in 2020. These codes are time-tiered, meaning accurate start/stop time tracking is a documentation requirement, not a best practice. Incorrect component separation is a major denial driver in payer audits.
| CPT | Description | Component | Billing Rule |
|---|---|---|---|
| 95700 | LTM setup, patient education, takedown | Technical | Bill once per monitoring episode |
| 95711 | LTM technical recording, 2–12 hours | Technical | Time-tiered |
| 95712 | LTM technical recording, 12–26 hours | Technical | Time-tiered |
| 95714 | LTM technical recording, 24–48 hours | Technical | Time-tiered |
| 95716 | LTM technical recording, >48 hours | Technical | Extended monitoring |
| 95718–95726 | LTM professional interpretation | Professional | Tiered by duration; requires signed report |
Global vs. Component EEG Billing and POS Rules
| Scenario | Modifier | POS | Who Bills What |
|---|---|---|---|
| Practice owns equipment + physician interprets | None (global) | POS 11 (office) | Full fee schedule |
| Hospital owns equipment; physician interprets only | –26 | POS 21/22 | Professional component only |
| Practice owns equipment; no physician interpretation billed | –TC | POS 11 | Technical component only |
Category III Codes for AI-Assisted EEG Analysis (2026)
Category III codes now support AI-assisted EEG waveform analysis. These remain investigational at most payers and require prior authorization and strong documentation of clinical utility. Key 2026 codes include X461T–X466T (continuous EEG monitoring services) and X504T (AI-supported EEG waveform analysis). A critical compliance requirement: AI-generated interpretations alone do not satisfy documentation standards — the treating provider must review the output and document the final clinical decision.
EMG & Nerve Conduction Studies
EMG and NCS services are core revenue drivers in neurology but are also among the most frequently audited services due to bundling errors, insufficient documentation of medical necessity, and incorrect study count coding. The 14% national procedural share of CPT 95886 makes it the single most commonly reported neurology code.
Needle EMG Codes (95860–95886)
| CPT | Description | 2026 wRVU | Clinical Use |
|---|---|---|---|
| 95860 | Needle EMG, 1 extremity | 0.90 | Localized neuropathy, radiculopathy screening |
| 95861 | Needle EMG, 2 extremities | 1.10 | Bilateral comparison studies |
| 95885 | Needle EMG, limited (same day as NCS) | 0.90 | Use when same-day NCS is performed; limited scope |
| 95886 | Needle EMG, complete (5+ muscles, 3+ nerves or 4+ spinal levels) | 1.56 | Suspected ALS, polyneuropathy, myopathy — comprehensive multi-extremity studies |
Nerve Conduction Study Codes (95907–95913)
NCS testing is billed based on the number and type of studies performed. Each direction of testing (motor, sensory, F-wave, or reflex study) counts as a separate study. Accurate study count directly drives code selection and reimbursement.
| CPT | Studies | 2026 wRVU | Typical Clinical Context |
|---|---|---|---|
| 95907 | 1–2 studies | 0.65 | Single nerve evaluation, carpal tunnel screening |
| 95908 | 3–4 studies | 0.85 | Limited mononeuropathy workup |
| 95909 | 5–6 studies | 1.05 | Moderate polyneuropathy evaluation |
| 95910 | 7–8 studies | 1.25 | Bilateral carpal tunnel, moderate neuropathy |
| 95911 | 9–10 studies | 1.45 | Comprehensive polyneuropathy, Guillain-Barré |
| 95912 | 11–12 studies | 1.65 | Extensive neuropathy evaluation |
| 95913 | 13+ studies | 1.85 | Complex motor neuron disease, multi-level radiculopathy |
Billing EMG and NCS Together: NCCI Bundling Rules
EMG and NCS are commonly billed together in the same encounter, but this creates NCCI bundling risk. The critical rule: Modifier –59 may only be used when the EMG and NCS are performed on different anatomical regions, each with separate documentation and independent medical necessity.
High Audit Risk:
Applying Modifier –59 to every combined EMG+NCS claim without documentation of distinct anatomical sites is a documented OIG fraud indicator in neurology. Ensure separate procedure notes exist for each service before appending –59.
Sleep Medicine & Polysomnography
Between 50 and 70 million Americans live with sleep disorders. Neurologists frequently order and interpret sleep studies for patients with epilepsy, Parkinson’s disease, and other conditions that disrupt sleep architecture. Correct code selection depends on the number of parameters monitored and whether a technician was present.
| CPT | Description | Technician Present? | Key Requirement |
|---|---|---|---|
| 95806 | Sleep study, unattended, with respiratory effort | No | Records airflow, respiratory effort, O2 saturation, heart rate, and position; no technician in room |
| 95810 | Polysomnography ≥6 parameters, attended, age 6+ | Yes | Full overnight study; monitors brain activity, eye movement, heart rate, breathing, O2 saturation, limb movement; requires physician interpretation |
| 95811 | Polysomnography with CPAP titration | Yes | CPAP titration documentation must be included; sleep apnea diagnosis required |
| 95807 | Sleep study, attended, without CPAP | Yes | Limited sleep monitoring without full polysomnography parameters |
All polysomnography claims require a formal, signed physician interpretation report. The interpretation must reference the recorded parameters and correlate findings with the patient’s clinical presentation.Â
Evoked Potentials & Autonomic Testing
Evoked potential studies measure the nervous system’s electrical response to sensory stimuli and are commonly used in MS evaluation, intraoperative monitoring, and spinal cord disease assessment.
| CPT | Description | Clinical Use |
|---|---|---|
| 95930 | Visual evoked potentials (VEP) | Multiple sclerosis, optic neuritis, cortical visual pathway evaluation |
| 95925 | SSEP, upper extremity | Cervical radiculopathy, thoracic outlet syndrome, intraoperative monitoring |
| 95926 | SSEP, lower extremity | Lumbar radiculopathy, spinal cord injury assessment |
| 95927 | SSEP, head or trunk | Brainstem lesion evaluation |
| 95938 | Short-latency SEP, upper and lower extremity | Comprehensive spinal cord assessment |
| 95919–95924 | Autonomic function testing | Autonomic neuropathy, Parkinson’s disease, POTS evaluation |
| 95940–95941 | Intraoperative neurophysiology monitoring | Continuous monitoring during spine/brain surgery |
Cognitive & Neuropsychological Testing
Cognitive assessment codes are among the most underutilized in neurology despite being highly relevant for dementia evaluation, Alzheimer’s workups, post-stroke cognitive assessment, and pre-surgical neuropsychological screening. These codes require face-to-face time with the patient and thorough documentation of administered tests and findings.
Neurobehavioral Status Exam (Physician-Administered)
| CPT | Description | Time | Documentation |
|---|---|---|---|
| 96116 | Neurobehavioral status exam, first hour | First 60 min face-to-face | Administered by physician or NPP; includes clinical assessment of cerebral functions, cognitive testing, and interpretation |
| 96121 | Neurobehavioral status exam, each additional hour | Add-on per hour | Must be reported with 96116; cannot be reported alone |
Neuropsychological Testing (Psychologist or NPP Administered)
| CPT | Description | Time | Notes |
|---|---|---|---|
| 96130 | Neuropsychological testing evaluation, first hour | First 60 min | Administered and interpreted by qualified provider; includes integration of patient history, test results, and report |
| 96131 | Neuropsychological testing evaluation, each add-on hour | Add-on per hour | Report with 96130 |
| 96132 | Neuropsychological testing administration, first hour | First 60 min | Technician-administered; requires qualified provider oversight |
| 96133 | Neuropsychological testing administration, each add-on hour | Add-on per hour | Report with 96132 |
Telehealth Opportunity:
CPT codes 96130–96133 are recognized under Appendix T for audio-only billing allowances in specific payer policies, making them eligible for tele-neurology delivery at some payers. Verify coverage before scheduling remote neuropsychological testing sessions.
Chemodenervation / Botulinum Toxin Billing
Chemodenervation is a high-volume, high-scrutiny service in neurology for chronic migraine, spasticity, dystonia, and hyperhidrosis. Incorrect drug-procedure bundling and missing documentation are the two most common denial causes for this service category.
Procedure Codes
| CPT | Description | Key Requirement |
|---|---|---|
| 64615 | Chemodenervation of facial, neck, or scalp muscles — chronic migraine | Diagnosis: chronic migraine confirmed (≥15 headache days/month, ≥8 migraine days); PREEMPT protocol site documentation; failed prior preventive therapies |
| 64612 | Chemodenervation of facial nerve | Facial dystonia or hemifacial spasm; document anatomical sites and units |
| 64616 | Chemodenervation of neck muscles — cervical dystonia, not for migraine | Cervical dystonia; document number of muscles and units per muscle |
| 64642 | Chemodenervation of extremity muscles — 1 extremity | Spasticity from stroke, MS, TBI; document affected limb and functional goals |
| 64643 | Each additional extremity — add-on to 64642 | Cannot be billed standalone; always report with 64642 as primary code |
Drug Supply Codes (Always Bill Separately)
| HCPCS | Drug | Per Unit Billing |
|---|---|---|
| J0585 | OnabotulinumtoxinA (Botox) per unit | 1 billed unit = 1 administered unit; never bundle with procedure code |
| J0586 | AbobotulinumtoxinA (Dysport) per unit | Units are NOT interchangeable with Botox; document brand administered |
| J0587 | RimabotulinumtoxinB (Myobloc) per unit | Used for cervical dystonia; separate unit conversion from onabotulinumtoxinA |
PREEMPT Protocol for Migraine (64615):
Most payers require documentation of the PREEMPT injection pattern for chronic migraine — 31 fixed-site, fixed-dose injections across 7 specific head and neck muscle groups totaling 155 units of onabotulinumtoxinA minimum. Document injection site diagram or grid in the chart note, not just total units administered. Frequency is limited toone treatment cycle every 12 weeksby most payers including Medicare.
Interventional Neurology: SCS & Deep Brain Stimulation
Spinal Cord Stimulation (SCS)
| CPT | Description | Key Requirement |
|---|---|---|
| 63650 | SCS trial — percutaneous electrode placement | Document pain severity scale (VAS/NRS); confirm prior conservative treatment failure; typically 3–7 day trial period |
| 63655 | SCS permanent — laminotomy/laminectomy electrode placement | Requires positive trial outcome (≥50% pain reduction); prior auth mandatory |
| 63685 | Insertion/replacement of spinal neurostimulator pulse generator | Report with electrode placement codes if done concurrently |
Deep Brain Stimulation (DBS) — Full Billing Cycle DIFFERENTIATOR
DBS is the highest-complexity neurostimulator service in neurology. Billing spans three distinct phases: surgical implantation, pulse generator placement, and ongoing programming — each with separate codes and documentation requirements.
| CPT | Description | Phase |
|---|---|---|
| 61850 | Twist drill or burr hole for implantation of electrode | Surgical — electrode implantation |
| 61863 | Twist drill or burr hole for electrode implant, first array | Surgical — first array (e.g., STN for Parkinson’s) |
| 61864 | Each additional electrode array | Surgical — add-on to 61863 |
| 61886 | Insertion/replacement of cranial neurostimulator pulse generator | Surgical — generator placement |
| 61889 | Revision or removal of cranial neurostimulator | Surgical — device adjustment/complications |
DBS Programming — Time-Based Codes (95983–95984)
After DBS implantation, ongoing programming is a separately billable service billed using time-based codes. These codes require documented face-to-face time and cannot be billed if the encounter is less than 8 minutes.
| Total Face-to-Face Time | Code(s) to Report |
|---|---|
| Less than 8 minutes | Do not report |
| 8–22 minutes | 95983 × 1 |
| 23–37 minutes | 95983 × 1 + 95984 × 1 |
| 38–52 minutes | 95983 × 1 + 95984 × 2 |
| 53–67 minutes | 95983 × 1 + 95984 × 3 |
| 68 minutes or longer | 95983 × 1 + add units of 95984 |
CGRP Monoclonal Antibodies for Migraine Prevention NEW 2026
CGRP-targeted biologics represent a newer preventive therapy class for chronic migraine and are billed separately from chemodenervation procedures. These drugs require separate HCPCS J-codes, prior authorization, and documented step therapy failure before approval at most payers.
| Drug | HCPCS Code | Route | Prior Auth Requirement |
|---|---|---|---|
| Erenumab (Aimovig) | J3380 | Subcutaneous | Step therapy: failure of ≥2 oral preventive agents (beta-blocker, anticonvulsant, TCA) |
| Fremanezumab (Ajovy) | J3031 | Subcutaneous | Same step therapy requirements as erenumab |
| Galcanezumab (Emgality) | J2792 | Subcutaneous | Step therapy; also FDA-approved for episodic cluster headache |
| Eptinezumab (Vyepti) | J3032 | IV infusion | Step therapy; bill 96365 for IV administration in addition to drug J-code |
Medicare Part B covers injectable CGRP biologics when administered in the office setting. Medicare Part D applies to self-administered versions. Verify which route and setting applies for each patient before billing.
Lumbar Puncture
Lumbar puncture (spinal tap) is a frequently performed and frequently under-coded procedure in neurology. Correct code selection depends on whether the procedure is diagnostic (CSF analysis) or therapeutic (ICP reduction). Documentation must include the clinical indication, patient positioning, needle insertion level, volume of CSF removed or analyzed, and any complications.
| CPT | Description | Clinical Indication | Documentation Required |
|---|---|---|---|
| 62270 | Diagnostic lumbar puncture | Meningitis, subarachnoid hemorrhage, multiple sclerosis (oligoclonal bands), CNS infection, Guillain-Barré workup, dementia biomarker testing | Indication, needle level, CSF appearance, volume removed, sent for analysis |
| 62272 | Therapeutic lumbar puncture — with removal of CSF | Idiopathic intracranial hypertension, normal pressure hydrocephalus, post-myelogram headache relief | Opening and closing pressure, volume removed, symptom response documented |
Dementia Biomarker Testing via LPÂ DIFFERENTIATOR
CSF biomarker testing for Alzheimer’s disease — amyloid beta 42/40 ratio and phosphorylated tau — is increasingly required before initiating anti-amyloid therapy (lecanemab, donanemab). These tests are billed under CPT 81479 or payer-specific Proprietary Lab Analyses (PLA) codes. Coverage is highly variable and prior authorization is commonly required. The LP itself is separately billable under 62270.
Neuroimaging
Neurologists commonly order and/or interpret brain and spinal imaging. Modifier application depends entirely on which billing component — professional, technical, or global — the practice is providing.
| CPT | Procedure | Clinical Use Case | Modifier Rule |
|---|---|---|---|
| 70551 | MRI brain, without contrast | Seizures, MS lesion screening, structural evaluation | Mod –26 if interpretation only |
| 70552 | MRI brain, with contrast | Tumor, abscess, active inflammation | Mod –26 if interpretation only |
| 70553 | MRI brain, with and without contrast | Complex lesion evaluation, MS follow-up, post-operative | Mod –26 if interpretation only |
| 70450 | CT head, without contrast | Stroke, trauma, acute headache, hemorrhage | Mod –26 if interpretation only |
| 70460 | CT head, with contrast | Post-operative, suspected mass | Mod –26 if interpretation only |
| 78608 | PET brain | Alzheimer’s disease, dementia evaluation, neurodegenerative disorders | Prior auth almost universally required; Mod –26 if interpretation only |
| 70540–70543 | MRI orbit/face/neck | Optic nerve, cranial nerve evaluation | Mod –26 if interpretation only |
Imaging Modifier Rules:
Modifier–26is required when the neurologist provides only professional interpretation of an imaging study performed elsewhere. Modifier–TCapplies when only the technical component is provided. If the practice provides both components (owns equipment and physician interprets),no modifier is needed. Incorrect modifier use is one of the most frequent denial triggers for neuroimaging claims.
Infusion Therapy for Neurological Conditions
Infusion therapy in neurology encompasses disease-modifying therapies (DMTs) for multiple sclerosis, immunotherapy for autoimmune neuropathies, and high-cost anti-amyloid biologics for Alzheimer’s disease. All infusion claims require documented start and stop times — missing time documentation is the leading denial cause for this code category.
IV Infusion Administration Codes
| CPT | Description | Billing Rule |
|---|---|---|
| 96365 | Initial IV infusion, therapeutic/prophylactic, up to 1 hour | Bill once per infusion encounter; document start/stop time |
| 96366 | Each additional hour beyond first | Add-on to 96365; bill in whole hours; partial hours >30 min round up |
| 96367 | Sequential infusion, new substance, up to 1 hour | Use when a second drug infuses after the first drug completes |
| 96368 | Concurrent infusion | Second substance infuses simultaneously with primary; bill once regardless of duration |
| 96413 | Chemotherapy infusion, initial, up to 1 hour | Use for high-cost biologic agents classified as chemotherapy (e.g., natalizumab/Tysabri) |
MS Disease-Modifying Therapy (DMT) HCPCS Codes
| Drug | HCPCS | Route | Administration Code |
|---|---|---|---|
| Natalizumab (Tysabri) | J2323 | IV infusion | 96413 (chemotherapy-class infusion) |
| Ocrelizumab (Ocrevus) | J2350 | IV infusion | 96365 + 96366 as applicable |
| Ofatumumab (Kesimpta) | J3031 | Subcutaneous | 96401 for subcutaneous injection |
| Alemtuzumab (Lemtrada) | J0202 | IV infusion | 96413 + 96415 (chemotherapy-class) |
Anti-Amyloid Therapy for Alzheimer’s Disease DIFFERENTIATOR
CMS has issued National Coverage Determinations (NCDs) for anti-amyloid therapies. Medicare covers these agents under a Coverage with Evidence Development (CED) framework, requiring patient enrollment in qualifying registries. Prior authorization is mandatory, and biomarker confirmation of amyloid pathology is a prerequisite for initiation.
| Drug | HCPCS | Route | CMS Coverage Requirements |
|---|---|---|---|
| Lecanemab (Leqembi) | J0173 | IV infusion (q2 weeks) | CED registry enrollment; amyloid PET or CSF biomarker confirmation; mild cognitive impairment or mild Alzheimer’s dementia diagnosis; no significant vascular pathology on MRI |
| Donanemab (Kisunla) | J0172 | IV infusion (monthly) | Same CED framework as lecanemab; ARIA monitoring MRI required per protocol |
Both drugs require pre-treatment MRI to screen for amyloid-related imaging abnormalities (ARIA). Bill infusion administration under 96365 + 96366 for each infusion session, with the appropriate drug J-code on a separate line. Document infusion duration, ARIA monitoring status, and registry enrollment in every encounter note.
Chronic Care Management (CCM) in Neurology
CCM codes represent a significant and frequently underutilized billing opportunity in neurology. Patients with multiple sclerosis, Parkinson’s disease, epilepsy, and Alzheimer’s disease have among the highest CCM eligibility rates in any specialty. CCM requires at least two chronic conditions expected to last 12+ months and at least 20 minutes of non-face-to-face clinical management time per calendar month.
| CPT | Description | Time Threshold | Typical Neurology Use |
|---|---|---|---|
| 99490 | Chronic Care Management, 20 min/month clinical staff time | 20 min/month | MS, Parkinson’s disease, epilepsy, Alzheimer’s management |
| 99439 | CCM add-on, each additional 20 minutes | +20 min/month | Complex patients with multiple comorbidities |
| 99491 | Complex CCM, physician/NPP ≥30 min/month | 30 min/month physician time | High-complexity neurological disease management |
CCM billing requires: (1) written or verbal patient consent documented at the time of enrollment, (2) a comprehensive care plan addressing all chronic conditions, (3) 24/7 access to clinical staff, and (4) documented monthly management time. Each month’s claim must reflect actual time and activities performed — not a boilerplate carry-forward from prior months.
ICD-10-CM Codes in Neurology (2026)
Accurate ICD-10 code selection is essential to establish medical necessity for neurological procedures and services. Use the most specific code available — “unspecified” codes should only be used when documentation genuinely does not support a more specific selection.
| Condition | ICD-10 Code(s) | Clinical Notes |
|---|---|---|
| Epilepsy (localization-related, intractable) | G40.219 | Specify: localization-related vs. generalized; intractable vs. not; with/without status epilepticus |
| Epilepsy (generalized, not intractable) | G40.309 | Use specific subcategories: G40.3xx for generalized |
| Migraine without aura, intractable | G43.019 | Distinguish episodic vs. chronic; with/without status migrainosus |
| Chronic migraine without aura | G43.709 | Required for Botox (64615) authorization at most payers |
| Parkinson’s disease | G20 | Add secondary codes for dementia, dysphagia, or autonomic dysfunction if present |
| Multiple sclerosis | G35 | Single code; add functional status codes as applicable |
| Alzheimer’s disease, early onset | G30.0 | Use G30.1 for late onset; add F02.80 or F02.81 for behavioral disturbance |
| Peripheral neuropathy, unspecified | G60.9 | Specify etiology if known: diabetic (E11.40), hereditary, inflammatory |
| Diabetic peripheral neuropathy | E11.40 | Sequence diabetes code first; add G code for specific manifestation |
| Cerebral infarction | I63.xx | Specify location and etiology; I63.00–I63.9 range; use Z87.39 for history |
| TIA | G45.9 | Subclassify by artery if documented: G45.0 (vertebrobasilar), G45.1 (carotid) |
| Carpal tunnel syndrome | G56.01 / G56.02 | Right = .01; Left = .02; Bilateral = .03; laterality is required |
| Radiculopathy, cervical | M54.12 | Specify level if documented; M54.12 = cervical, M54.16 = lumbar |
| Headache, unspecified | R51.9 | Use only when specific headache type not yet established; do not use if migraine diagnosis confirmed |
ICD-10 Sequencing Rule:
Use symptom codes (R codes) when a confirmed diagnosis has not yet been established. Once a diagnosis is confirmed, replace symptom codes with the specific condition code. For chronic disease management visits, sequence the condition being managed as the primary diagnosis — not the reason for a specific procedure unless that procedure is the sole purpose of the visit.
Documentation Requirements for Neurology Billing (2026)
Neurology claims require detailed, encounter-specific documentation across three areas:Â
Clinical DocumentationÂ
- Neurological exam findingsÂ
- Symptom onset and durationÂ
- Cognitive status assessmentÂ
- Functional limitations documentedÂ
Diagnostic DocumentationÂ
- Clinical rationale for ordering the testÂ
- Signed interpretation reportÂ
- Correlation between test findings and diagnosisÂ
Treatment DocumentationÂ
- Medication changes and responseÂ
- Injection site documentation for chemodenervation proceduresÂ
- Patient response to therapy over timeÂ
Tele-Neurology & Remote Monitoring (2026)
Tele-neurology is one of the fastest-growing service delivery models in the specialty. Key billable areas include virtual neurology consultations, remote EEG interpretation, Remote Physiologic Monitoring (RPM), and Remote Therapeutic Monitoring (RTM).Â
Billing Considerations:Â
- Payer parity rules vary significantly by state and plan — verify coverage before schedulingÂ
- Place of Service (POS) code selection is critical for correct reimbursementÂ
- Documented patient consent is required for all telehealth and remote monitoring servicesÂ
Provider & Credentialing Requirements
Neurology billing depends on several provider-level factors that must be maintained and verified:Â
- Board certification in neurology or relevant subspecialtyÂ
- Active payer enrollment under the rendering provider’s NPIÂ
- Compliance with payer supervision guidelinesÂ
- Current hospital privileging for inpatient neurology servicesÂ
Some services — including credentialed EEG/EMG interpretation and certain diagnostic procedures — require a supervising physician to be documented in the record.Â
Insurance & Payer Considerations
Neurology is one of the most heavily reviewed specialties by payers due to the high cost of imaging, nerve testing, and injectable therapies. Common payer requirements include:Â
- Prior authorization for MRI, PET scans, and long-term EEG monitoringÂ
- Supporting documentation for chronic migraine chemodenervation (e.g., failed preventive medications)Â
- Medical necessity documentation for nerve conduction studies (NCS) and EMGÂ
Always pre-verify authorization requirements before scheduling high-cost diagnostic or interventional procedures.Â
Common Neurology Billing Denials (2026)
Denial Type | Root Cause | Prevention Strategy |
Medical necessity | Weak or incomplete documentation | Link symptoms clearly to diagnosis; document functional impact |
NCCI bundling | Code pairs billed together incorrectly | Review NCCI edits before submitting code combinations |
Missing modifier | TC or 26 not applied to imaging/diagnostic claims | Verify which billing component applies before submission |
Frequency limits exceeded | EEG or EMG billed beyond payer limits | Document clinical change justifying repeat testing |
Authorization failure | Imaging or procedures not pre-authorized | Pre-verify all high-cost services before scheduling |
NCCI & Compliance Updates (2026)
CMS and commercial payers are prioritizing the following neurology compliance areas in 2026:Â
- EEG and EMG bundling scrutiny — review all code pairs against current NCCI editsÂ
- Imaging and E&M overlap audits — ensure Modifier 25 is applied when both are billed on the same dayÂ
- Chemodenervation frequency checks — document medical necessity for each treatment cycleÂ
- Neolytix • Medical Billing
Medical Billing
AI & Diagnostic Coding Compliance
Payers are actively auditing AI-assisted diagnostic services in neurology, including AI-assisted EEG interpretation and automated neuroimaging reports. Key requirements:Â
- Physician review must be documented for all AI-assisted outputsÂ
- Final clinical decision must be made and recorded by the treating provider — AI-generated interpretations alone do not satisfy documentation requirementsÂ
Revenue Cycle Best Practices for Neurology
To optimize neurology billing performance and reduce revenue leakage:Â
- Use specialty-specific coding workflows tailored to neurology service typesÂ
- Conduct regular audits of EMG and NCS claims for accuracy and complianceÂ
- Verify prior authorization before scheduling imaging or interventional proceduresÂ
- Monitor modifier usage patterns across the billing teamÂ
- Implement denial analytics to identify and address recurring claim rejection patternsÂ
Future Trends in Neurology Billing
Neurology practices should prepare for continued evolution in the following areas:Â
- Digital therapeutics for neurological conditions (e.g., app-based MS and epilepsy management)Â
- Neuro-monitoring programs billed under RPM and RTM frameworksÂ
- Chronic disease management programs for Parkinson’s, MS, and epilepsyÂ
- AI-assisted diagnostics with emerging payer documentation requirementsÂ
Staying current with annual CPT updates, ICD revision cycles, and payer policy changes is essential to maintaining compliant and optimized neurology billing.Â
How Neolytix Supports Neurology Practices
Neurology billing demands specialty-level expertise. Between EEG and EMG compliance, modifier complexity, neuroimaging authorization, and tele-neurology billing rules, errors compound quickly — and audits are frequent.Â
At Neolytix, we provide:Â
- Specialty-specific medical billing and coding for neurology practicesÂ
- Medical coding audit services to identify gaps and reduce denial ratesÂ
- Revenue cycle management to accelerate collections and improve cash flowÂ
- Tele-neurology billing support including POS, modifier, and payer compliance guidanceÂ
With over 14 years of experience supporting healthcare organizations across the United States, Neolytix brings the expertise your neurology practice needs to stay compliant, reduce denials, and protect revenue.Â
- Neolytix • Contact Us
Schedule a Consultation
Neolytix partners with healthcare organizations across revenue cycle, credentialing, and administrative operations ,14+ years of expertise and AI-enabled automation to reduce inefficiencies and drive sustainable growth.
This guide reflects Neolytix’s expertise in healthcare revenue cycle management and is intended for educational purposes only. It does not constitute legal or compliance advice. CPT codes and reimbursement rates are periodically updated by the AMA and CMS. Always verify current codes and rates using the CMS Physician Fee Schedule Lookup Tool and the AMA CPT code database.
Frequently Asked Questions
What CPT codes are used for EEG billing in neurology?
The most commonly used EEG codes are 95816 (routine EEG), 95812 (EEG 41–60 minutes), and 95813 (EEG over 1 hour). Long-term EEG monitoring is coded with the 95700–95726 series. Each requires a signed physician interpretation report.Â
How is E&M level determined for neurology visits in 2026?
E&M level is based on either Medical Decision Making (MDM) or total time spent on the date of service. Neurology encounters managing complex or chronic conditions such as epilepsy, multiple sclerosis, or Parkinson’s disease typically qualify for moderate to high complexity MDM.
What documentation is required for chemodenervation (Botox) billing in neurology?
Documentation should include the clinical indication (e.g., chronic migraine, spasticity, dystonia), a record of failed alternative treatments, injection site documentation, and the units of drug administered. HCPCS J-codes for the drug supply must also be included on the claim.
What modifiers are required for neuroimaging billed by a neurology practice?
Modifier 26 is required when the neurology practice provides only the professional interpretation of an imaging study. Modifier TC applies when only the technical component is performed. If both components are provided by the same practice, no modifier is needed.Â
What are the most common neurology billing denials and how can they be prevented?
The most frequent denials involve medical necessity (weak documentation), NCCI bundling errors, missing modifiers on imaging claims, frequency limit violations for EEG/EMG, and prior authorization failures for high-cost imaging. A structured pre-submission review and regular coding audits are the most effective prevention strategies.
Sources & References
- CMS Physician Fee Schedule Look-Up Tool — Centers for Medicare & Medicaid Services
- Federal Register: CY 2026 Medicare Physician Fee Schedule Final Rule — U.S. Federal Register
- CPT Code Overview and Approval Process — American Medical Association
- National Correct Coding Initiative (NCCI) Edits — CMS
- CMS Local Coverage Determination: Electroencephalography (EEG) — CMS
- CMS Local Coverage Determination: Nerve Conduction Studies & EMG — CMS
- OIG Fraud Prevention & Compliance Resources — Office of Inspector General, HHS
- CMS 2026 Medicare Telehealth Services List — CMS
- CMS Remote Physiologic Monitoring (RPM) Policy — CMS
- CMS QPP MIPS Quality Measures Library — Quality Payment Program
- American Academy of Neurology (AAN) Coding & Reimbursement Resources — American Academy of Neurology
- CMS Local Coverage Determinations (LCDs) Database — CMS
- AAPC Certified Professional Coder (CPC) Certification — AAPC
- CMS Medicare Administrative Contractors (MACs) — CMS